ClinicalTrials.Veeva

Menu
V

Velocity Clinical Research | Syracuse, NY

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

JNJ-64042056
Gantenerumab
[18F]PI-2620
RG7774
JNJ-63733657
Resmetirom

Parent organization

This site is a part of Velocity Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 7 total trials

[18F]PI-2620 Phase 3 Histopathological Study

This study is an open-label, multi-center, non-randomized pivotal Phase 3 study to assess the efficacy and safety of PET imaging with \[18F\]PI-2620...

Enrolling
Alzheimer Disease
Drug: [18F]PI-2620

A 52-Week, Multi-center, Open-label, Active Treatment Extension Study to Evaluate Safety and Tolerability of Once Daily, Oral Administration of Resme...

Active, not recruiting
Non-Alcoholic Fatty Liver Disease
Drug: Resmetirom

The main objective of Part A of this trial is to evaluate the safety and reactogenicity of mRNA-1189 in 18- to 30-year-old healthy adults, the main o...

Active, not recruiting
Epstein-Barr Virus Infection
Biological: mRNA-1189
Biological: Placebo

The purpose of this study is to assess whether JNJ-64042056 affects the spread and build up of tau (a protein in brain) when compared with placebo, u...

Active, not recruiting
Alzheimer Disease
Drug: JNJ-64042056
Drug: Placebo

Trial sponsors

Roche logo
Janssen (J&J Innovative Medicine) logo
Janssen (J&J Innovative Medicine) logo
Madrigal Pharmaceuticals logo
Moderna logo
L

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems